An AI model trained on nearly one million bacterial genomes can predict when and where antibiotic resistance genes are likely ...

For millions of years, frogs have flourished in microbial swamps yet rarely falling ill. To survive these hostile environments, they evolved potent chemical defenses. Now, scientists are learning to ...

Acquired resistance genes may allow bacteria to degrade or chemically modify antibiotics, rendering them ineffective. They ...

Akagera Medicines, a Rwandan biotech company has announced promising results after completing early stages of preclinical trials of an antibiotic drug for the treatment of pulmonary tuberculosis (TB).

Biology — the science of life, living things and the processes that keep us all running — links up in essential ways with ...

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

Having stripped back its workforce, antibiotics biotech Spero Therapeutics continues to strip away its remaining pipeline. | ...

Engineered frog-derived peptides may become powerful new antibiotics, showing strong results against resistant bacteria in ...

The FDA approved GSK's Blujepa for uncomplicated UTIs in female adults and pediatric patients, with phase 3 trials showing strong efficacy vs. nitrofurantoin.

In seeking new antibiotic sources, researchers have turned to an unlikely source: a whiffy frog known as Odorrana andersonii.

Investment bankers say large pharma and biotech deals are stalling as executives grapple with mercurial White House economic ...

Researchers created safe synthetic antibiotics from frog molecules. These may help fight superbugs in the future.